AXL and hepatocellular carcinoma: Furthermore, AXL has been found to promote the transition of macrophages from an anti-tumorigenic M1-like phenotype to a tumorigenic M2-like phenotype [38], and it has been implicated in inducing sorafenib resistance in HCC by increasing the population of M2-like macrophages [39].